Cargando…

Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression

BACKGROUND: Psychotic depression has no Food and Drug Administration–approved treatment. Patients demonstrate significant dysregulation of the hypothalamic-pituitary-adrenal axis providing a biologically targeted treatment opportunity. The purpose of this study was to explore the clinical and biolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Block, Thaddeus, Petrides, Georgios, Kushner, Harvey, Kalin, Ned, Belanoff, Joseph, Schatzberg, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596828/ https://www.ncbi.nlm.nih.gov/pubmed/28708736 http://dx.doi.org/10.1097/JCP.0000000000000744

Ejemplares similares

Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer
por: Baker, Gabrielle M, et al.
Publicado: (2015)

Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription
por: Ma, Peng, et al.
Publicado: (2021)

Resetting the Stress System with a Mifepristone Challenge
por: Dalm, Sergiu, et al.
Publicado: (2018)

Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
por: Parker, John C., et al.
Publicado: (2021)

Cross-sectional and longitudinal associations between psychotic and depressive symptoms in depressed adolescents
por: Kehinde, Fiona, et al.
Publicado: (2021)

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study
por: East, Honey E, et al.
Publicado: (2022)

The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression
por: Vos, Cornelis F., et al.
Publicado: (2023)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

Primary Generalized Glucocorticoid Hypersensitivity Treated with Mifepristone: A Case Report
por: Liu, Yunfeng, et al.
Publicado: (2020)

Two cases of infantile-onset primary generalized glucocorticoid hypersensitivity and the effect of mifepristone
por: Zhao, Xiu, et al.
Publicado: (2022)

Antagonisms between Opium and Belladona
por: Ware, Lyman
Publicado: (1871)

The Antagonism between Opium and Bella-Donna
por: Cerna, David
Publicado: (1892)

Doctors
por: Ned,
Publicado: (1876)

Doctors
por: Ned,
Publicado: (1876)

Dr. Ned’s Reflections
por: Ned,
Publicado: (1876)

Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men
por: Nguyen, Dat, et al.
Publicado: (2017)

Opium and Quinia Sulpatis: Their Antagonism and Co-operation
por: Fitch, T. D.
Publicado: (1864)

Sustained weight loss in patients treated with mifepristone for Cushing’s syndrome: a follow-up analysis of the SEISMIC study and long-term extension
por: Fein, Henry G., et al.
Publicado: (2015)

Season of birth effect on psychotic-like experiences in Japanese adolescents
por: Tochigi, Mamoru, et al.
Publicado: (2012)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

Circadian Clock, Glucocorticoids and NF-κB Signaling in Neuroinflammation- Implicating Glucocorticoid Induced Leucine Zipper as a Molecular Link
por: Srinivasan, Mythily, et al.
Publicado: (2022)

GLUCOCORTICOID-INDUCED HYPERTENSION AND CARDIAC INJURY: EFFECTS OF MINERALOCORTICOID AND GLUCOCORTICOID RECEPTOR ANTAGONISM
por: HATTORI, TAKUYA, et al.
Publicado: (2013)

Mifepristone Increases the Cytotoxicity of Uterine Natural Killer Cells by Acting as a Glucocorticoid Antagonist via ERK Activation
por: Chen, Yuezhou, et al.
Publicado: (2012)

A Single-Day Treatment with Mifepristone Is Sufficient to Normalize Chronic Glucocorticoid Induced Suppression of Hippocampal Cell Proliferation
por: Hu, Pu, et al.
Publicado: (2012)

Protective effects of glucocorticoid receptor antagonist Mifepristone on fear memory extinction impairment in a rat model of PTSD
por: Liu, Y.-P., et al.
Publicado: (2022)

Proteolytic enzyme arbitrated antagonization of helminthiasis by Cinnamomum cappara leaf extract in Pheretima posthuma
por: Vadakkan, Kayeen, et al.
Publicado: (2021)

Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats
por: Khom, Sophia, et al.
Publicado: (2022)

Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications
por: Gallagher, Peter, et al.
Publicado: (2006)

Double-blind, placebo-controlled trial of mifepristone on cognition and depression in alcohol dependence
por: Donoghue, Kim, et al.
Publicado: (2020)

Clinical and cognitive risk factors for psychotic symptoms in 22q11.2 deletion syndrome: a transversal and longitudinal approach
por: Schneider, Maude, et al.
Publicado: (2013)

Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
por: Asagami, Tomoko, et al.
Publicado: (2011)

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
por: Greenstein, Andrew E., et al.
Publicado: (2021)

Sleep disorders predict the 1-year onset, persistence, but not remission of psychotic experiences in preadolescence: a longitudinal analysis of the ABCD cohort data
por: Reeve, Sarah, et al.
Publicado: (2022)

Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Mifepristone, preemption, and public health federalism
por: Zettler, Patricia J, et al.
Publicado: (2022)

Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats
por: Vozella, Valentina, et al.
Publicado: (2021)

Understanding anhedonia: a qualitative study exploring loss of interest and pleasure in adolescent depression
por: Watson, Rebecca, et al.
Publicado: (2019)

Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease
por: Heier, Christopher R, et al.
Publicado: (2016)

Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases
por: De Nicola, Alejandro F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qljrdo5n7ujq888tcpr8s3kfkk